TY - JOUR
T1 - Epidemiology and surveillance of human (neuro)cysticercosis in Europe
T2 - is enhanced surveillance required?
AU - Abraham, Annette
AU - Schmidt, Veronika
AU - Kaminski, Miriam
AU - Stelzle, Dominik
AU - De Meijere, Robert
AU - Bustos, Javier
AU - Sahu, Priyadarshi Soumyaranjan
AU - Garcia, Hector Hugo
AU - Bobić, Branko
AU - Cretu, Carmen
AU - Chiodini, Peter
AU - Deksne, Gunita
AU - Dermauw, Veronique
AU - Devleesschauwer, Brecht
AU - Dorny, Pierre
AU - Fonseca, Ana
AU - Gabriël, Sarah
AU - Gómez-Morales, Maria Angeles
AU - Kucsera, István
AU - Laranjo-González, Minerva
AU - Trevisan, Chiara
AU - Vilhena, Manuela
AU - Walker, Naomi F.
AU - Zammarchi, Lorenzo
AU - Winkler, Andrea Sylvia
N1 - Publisher Copyright:
© 2020 The Authors Tropical Medicine & International Health Published by John Wiley & Sons Ltd
PY - 2020/5/1
Y1 - 2020/5/1
N2 - Objectives: To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000–2016. Methods: (N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians and a search for relevant ‘International Statistical Classification of Diseases and Related Health Problems’ (ICD)-based data. Results: Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3489 cases (N)CC cases were coded: 832 in Italy, eight in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden. Conclusion: Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.
AB - Objectives: To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000–2016. Methods: (N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians and a search for relevant ‘International Statistical Classification of Diseases and Related Health Problems’ (ICD)-based data. Results: Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3489 cases (N)CC cases were coded: 832 in Italy, eight in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden. Conclusion: Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.
KW - Europe
KW - epidemiology
KW - neurocysticercosis
UR - https://www.scopus.com/pages/publications/85082710866
U2 - 10.1111/tmi.13384
DO - 10.1111/tmi.13384
M3 - Artículo
C2 - 32083787
AN - SCOPUS:85082710866
SN - 1360-2276
VL - 25
SP - 566
EP - 578
JO - Tropical Medicine and International Health
JF - Tropical Medicine and International Health
IS - 5
ER -